Our study showed for the first time that CD47highCD68high represented an even better independent predictor for poor prognosis compared to the expression of CD47 or CD68 alone in breast cancer patients, especially in patients lacking of hormone receptor. The gene discussed is NR4A1; the disease is breast cancer.